AI-aided Design of Novel Targeted Covalent Inhibitors Against SARS-CoV-2

doi 10.1101/2020.03.03.972133
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Fully Human Single-Domain Antibodies Against SARS-CoV-2

2020English

SARS-CoV-2: A Potential Novel Etiology of Fulminant Myocarditis

Herz
Cardiovascular MedicineCardiology
2020English

Design and Study of Novel Peptide Inhibitors Against the SARS-Coronavirus Spike Protein

2006English

Discovery of Baicalin and Baicalein as Novel, Natural Product Inhibitors of SARS-CoV-2 3CL Protease in Vitro

2020English

Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights

2020English

Hypothesis: Advanced Biotechnological Treatment Approaches Against SARS-CoV-2 (COVID-19)

Volume 5 - 2020, Issue 4 - April
2020English

SARS-COV-2 and Infectivity

Journal of Medical Virology
VirologyInfectious Diseases
2020English

ACE2 Fragment as a Decoy for Novel SARS-Cov-2 Virus

2020English

De Novo Design of High-Affinity Antibody Variable Regions (scFv) Against the SARS-CoV-2 Spike Protein

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy